The syrup MucoGo contains the active substance carbocisteine. Carbocisteine is a mucolytic agent. The molecule of carbocisteine blocks chemically the sulfhydryl group (-SH), which is responsible for the mucus properties. In this way carbocisteine acts as a mucolytic. It affects also the synthesis of sialomucin by increasing its quantity, making easier the removal of secretions. Carbocisteine decreases the hyperplasia and hypertrophy of the zone that secretes mucus and at the same time acts locally as an antiphlogistic. By normalizing the secretion, carbocisteine acts as a regulator even in other structures where mucoproteine is synthetized e.g.: gastrointestinal apparatus, urogenital apparatus and middle ear.
MucoGo is indicated in the treatment of respiratory tract disorders associated with excessive, viscous mucus (bronchitis; bronchial asthma; pulmonary tuberculosis complicated with chronic bronchitis; rhinitis; sinusitis; laryngitis).